Onward Medical NV (XBRU:ONWD) 3-Year EBITDA Growth Rate : 16.60% (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Onward Medical NV 3-Year EBITDA Growth Rate?

Onward Medical NV's EBITDA per Share for the six months ended in Jun. 2023 was €-0.61.

During the past 3 years, the average EBITDA Per Share Growth Rate was 16.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 6 years, the highest 3-Year average EBITDA Per Share Growth Rate of Onward Medical NV was 16.60% per year. The lowest was -29.20% per year. And the median was -6.30% per year.

Competitive Comparison of Onward Medical NV's 3-Year EBITDA Growth Rate

For the Biotechnology subindustry, Onward Medical NV's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Onward Medical NV's 3-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Onward Medical NV's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Onward Medical NV's 3-Year EBITDA Growth Rate falls into.

Onward Medical NV 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Onward Medical NV (XBRU:ONWD) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Onward Medical NV 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Onward Medical NV's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Onward Medical NV (XBRU:ONWD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Onward Medical NV (XBRU:ONWD) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

ONWRF:USA 63E:Germany

Address

High Tech Campus 32, Noord-Braban, Eindhoven, NH, NLD, NL-5656 AE

Website

https://www.onwd.com

Onward Medical NV is a medical technology company developing and commercializing therapies to enable functional recovery for people with spinal cord injury. It has developed two programmable neurostimulation platforms: an implantable system, ARCIM, and a non-invasive, transcutaneous system, ARCEX. The company has selected the United states and four European markets: Germany, France, the UK and the Netherlands to create a customer base.

Onward Medical NV (XBRU:ONWD) Headlines

No Headlines